- Home » News and Events

NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities
Feb 23, 2021
Together, the addition of pDNA technology and production capabilities marks a significant milestone for Catalent Cell & Gene Therapy.
Catalent Announces Commercial Supply Agreement with Aurinia Pharmaceuticals for Newly-Approved LUPKYNIS™ Softgels
Feb 18, 2021
Catalent today announced that it recently signed a multi-year commercial supply agreement with Aurinia Pharmaceuticals, for LUPKYNIS™ (voclosporin), a drug to treat adult patients with lupus nephritis (LN).
Catalent Completes Acquisition of Dry Powder Inhaler Spray Drying, Capsule Manufacturing, and Packaging Capabilities from Acorda Therapeutics
Feb 15, 2021
Catalent has completed the acquisition of the manufacturing and packaging operations of Acorda Therapeutics, Inc., a developer of therapies to restore function and improve the lives of people with neurological disorders.
Catalent Launches CosmoPod® Duo – New Dual Chamber Capsule for Beauty and Consumer Health Topical Applications
Feb 9, 2021
Catalent today announced the launch of its CosmoPod® Duo softgel capsule technology for the delivery of topical skin treatments.
Catalent Signs Development and Manufacturing Agreement with Trizell for Macrophage-based Advanced Cell Therapy
Feb 8, 2021
Catalent today announced that it had signed an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.
Decibel and Catalent Sign Development and Manufacturing Agreement for Dual-Vector Gene Therapy for the Treatment of Congenital Hearing Loss
Feb 4, 2021
Catalent and Decibel Therapeutics today announced they have signed an agreement for Catalent to provide Decibel with process and analytical development, and CGMP clinical manufacturing services, for Decibel’s lead investigational gene therapy product candidate, DB-OTO.
Catalent Recognized as a Country Certified Top Employer 2021
Jan 25, 2021
Catalent today announced that it has been officially recognized by the Top Employers Institute as a Top Employer 2021 in the United States.
Catalent Agrees to Acquire Dry Powder Inhaler Spray Drying, Capsule Manufacturing, and Packaging Capabilities from Acorda Therapeutics
Jan 13, 2021
Catalent has entered into a definitive agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics, Inc. (Nasdaq: ACOR), a developer of therapies to restore function and improve the lives of people with neurological disorders.
Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program
Dec 21, 2020
Novan today announced an agreement with Catalent for the development of an intranasal formulation of berdazimer sodium for use in Novan’s COVID-19 program.
World ADC Europe 2021
Date: March 8-11, 2021
Scaling the Cell Therapy Supply Chain
Date: March 15, 2021
ISBiotech – 10th Spring Meeting Redux
Date: March 15-17, 2021
12th Global Drug Delivery & Formulation (DDF) Summit
Date: March 15-17, 2021
BEBPA US Bioassay Conference
Date: March 22-25, 2021
BIO-Europe Spring Digital
Date: March 22-25, 2021
Utilizing GPEx® Cell Line Development for Difficult-to-Express Proteins
Date: March 23, 2021
AAPS – Vaccine Stability Considerations to Enable Rapid Development and Deployment
Date: March 24-25, 2021
CTS Europe
Date: March 24-25, 2021
Clinical Trial Supply Roundtable Forum 2021
Date: March 30, 2021
Cell Gene Meeting on the Med
Date: April 6-9, 2021
Leveraging Advanced Tools to Shorten Biologic Development Timelines
Date: April 13, 2021
CASSS Bioassays Symposium 2021
Date: April 19-23, 2021
Formulation & Delivery Series Europe
Date: April 20-21, 2021
GCSG 2021 US Conference
Date: April 26-29, 2021
Highly Potent Active Pharmaceutical Ingredients
Date: May 10-11, 2021
PEGS Boston 2021
Date: May 11-13, 2021
ASGCT 24th Annual Meeting
Date: May 12-15, 2021